WO2024231843 - TRETINOIN LIPOSOME FORMULATIONS AND USES THEREOF TO TREAT CANCER
National phase entry is expected:
Publication Number
WO/2024/231843
Publication Date
14.11.2024
International Application No.
PCT/IB2024/054455
International Filing Date
07.05.2024
Title **
[English]
TRETINOIN LIPOSOME FORMULATIONS AND USES THEREOF TO TREAT CANCER
[French]
FORMULATIONS DE LIPOSOMES DE TRÉTINOÏNE ET LEURS UTILISATIONS POUR TRAITER LE CANCER
Applicants **
HIGHFIELD BIOPHARMACEUTICALS CORPORATION
Inventors
XU, Yuhong
ZHENG, Anjie
DAI, Yongchao
LIU, Jianmin
JIN, Shanshan
XU, Fengwei
WU, Xuan
WANG, Xun
GUO, Wenjun
HUANG, Yongfeng
Priority Data
202310535456.7
09.05.2023
CN
202310679399.X
08.06.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2544 | |
| EPO | Filing, Examination, Granting | 16265 | |
| Japan | Filing, Examination, Granting | 2647 | |
| South Korea | Filing, Examination, Granting | 3102 | |
| USA | Filing, Examination, Granting | 6940 |
Total:
31,498
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Described are methods for treating cancer an effective amount of all-trans retinoic acid (ATRA) disposed in a liposome.[French]
Sont décrites des méthodes de traitement du cancer, une quantité efficace d'acide tout-trans rétinoïque (ATRA) étant présente dans un liposome.